Atlas Trials

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

Clinical trial NCT07384975 · RECRUITING

Trial details

NCT number
NCT07384975
Sponsor
Navigator Medicines, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa (HS)
Start date
2026-01-05
Primary completion
2027-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.